Anxiety News and Research

Latest Anxiety News and Research

Scientist leads global discussion, research on insula

A scientist at Barrow Neurological Institute is leading the global discussion and research on a hidden lobe of the brain called the insula. A.D. "Bud" Craig, PhD, who began studying the often-ignored lobe more than two decades ago, has organized and edited a special edition of the journal Brain Structure and Function dedicated to the emerging medical and scientific interest in the insula.

8 Jul 2010

Pelosi urges Democrats to talk up health care; Businesses feel early impact of law

"Speaker Nancy Pelosi is doubling down on healthcare reform, betting that it will do Democrats more good than harm in November's elections," The Hill reports.

8 Jul 2010

First Edition: July 7, 2010

Today's biggest health policy news surrounds an announcement by the White House that President Obama will install a new Medicare and Medicaid chief with a recess appointment the bypasses the confirmation process.

7 Jul 2010

Therapist competence strongly related to symptom improvement in some patients: Study

While studies have shown that cognitive therapy is an effective treatment for depression, it has still not been clear the role therapists' training and expertise plays in making treatment successful. A new study finds that depressed patients show more symptom improvement when their therapists more competently follow the guidelines for delivering cognitive therapy.

7 Jul 2010

Anxiety can cause individuals become more idealistic in religious belief, researchers find

Anxiety and uncertainty can cause us to become more idealistic and more radical in our religious beliefs, according to new findings by York University researchers, published in this month's issue of the Journal of Personality and Social Psychology.

7 Jul 2010

FDA accepts DBV Technologies' IND for clinical study of VIASKIN for desensitization to peanut allergy

DBV Technologies (DBV), a biotech company specializing in food allergy with innovative products for diagnosis and treatment, announced today the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application. DBV Technologies will begin clinical investigation of its lead food allergy desensitization candidate, VIASKIN® PEANUT, for the desensitization to peanut allergy. The Company expects to commence recruitment of peanut allergy patients at several medical centers in the U.S. this month.

7 Jul 2010

Shire receives FDA approval of Daytrana for ADHD in adolescents

Shire plc, the global specialty biopharmaceutical company, announced the US Food and Drug Administration (FDA) approval of Daytrana® (methylphenidate transdermal system) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents aged 13 to 17 years. Daytrana, the first and only transdermal ADHD patch, is already an FDA-approved ADHD treatment for children 6 to 12 years. Daytrana is indicated as an integral part of a total treatment program for ADHD that may include other measures (psychological, educational, and social).

7 Jul 2010

Debate over the ill effects of wind turbines on health

The National Health and Medical Research Council (NHMRC) studied the purported ill effects of the wind turbines on health before reporting that there was no evidence that the turbines' low frequency noise or shadow flicker made people ill.

6 Jul 2010

Study finds maltreatment during childhood associated with mental health disorders in young adulthood

Abuse and neglect during childhood appear to be associated with increased rates of mood, anxiety and substance use disorders among young adults, according to a report in the June issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

6 Jul 2010

Anxiety disorders associated with higher risk of cardiovascular events, deaths in heart disease patients

Among patients with heart disease, anxiety disorders appear to be associated with a higher risk of stroke, heart attack, heart failure and death, according to a report in the July issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

6 Jul 2010

The heart and the psyche – Link between heart disease and anxiety-depressive disorders

According to a new report published in the acclaimed journal Archives of General Psychiatry, concomitant anxiety and other psychiatric illnesses in heart patients raise their risk of getting heart attacks, strokes, heart failure and early death.

5 Jul 2010

Chelsea reports positive outcome from DMC review of droxidopa Phase II trial in fibromyalgia

Chelsea Therapeutics International, Ltd. announced the completion and favorable outcome of an independent Data Monitoring Committee (DMC) review of the safety and efficacy data from approximately half the target enrollment in Chelsea's Phase II trial of droxidopa in fibromyalgia.

2 Jul 2010

Does too much texting puts teenagers at risk?

A seemingly harmless method of communication - text messaging on mobile phones could damage teenagers physically and psychologically a new study has revealed.

1 Jul 2010

Studies link anti-cholesterol statin drugs to increased risk of anxiety and depression

Scientists are reporting a possible explanation for the symptoms of anxiety and depression that occur in some patients taking the popular statin family of anti-cholesterol drugs, and reported by some individuals on low-cholesterol diets. These symptoms could result from long-term, low levels of cholesterol in the brain, the report suggests. It appears in ACS' weekly journal Biochemistry.

1 Jul 2010

Calmspace fragrance product to fight claustrophobia

Claustrophobia can be a debilitating condition and while there are a variety of therapies and treatments that attempt to limit its effects, there has never been a truly convenient, discreet and portable option for those seeking immediate and impactful relief in the event of an ensuing claustrophobic attack. Now, Healthy Brands LLC is introducing calmspace™, which delivers a proprietary therapeutic formula of 100% natural fragrance extracts that may help manage the anxiety resulting from claustrophobic reactions.

30 Jun 2010

New hope for patients with drug-resistant depression

New research shows that a unique strain of laboratory mice characterized at Penn State University has behavioral, hormonal, and neurochemical characteristics that are similar to those of human patients with drug-resistant forms of depression.

30 Jun 2010

FDA grants approval for first generic version of Effexor XR antidepressant capsules

On June 28, the U.S. Food and Drug Administration approved the first generic version of Effexor XR capsules (venlafaxine hydrochloride) to treat major depressive disorder.

30 Jun 2010

Oil spill disaster raises concern in the Gulf region

Two months after the Deepwater Horizon oil rig explosion caused the oil spill now globally acknowledged as the worst environmental disaster in our nation's history, the residents of the Gulf region immediately impacted are exhibiting dramatically high levels of anxiety, both among adults and children, about the future health and well-being of the region. Many children – and parents – still recovering from Katrina are now reeling from a second major trauma as a result of the oil catastrophe.

30 Jun 2010

Combination therapy for severe depression

Severe depression is life threatening. So it is worth every effort to get depression under control and make life more manageable. For most people, that means some combination of antidepressant drugs and talk therapy.

29 Jun 2010

New therapy for people suffering from body dysmorphic disorder

A nose job to treat a mental health problem? Teeth whitening to overcome a severe anxiety disorder? These are just two procedures that people with body dysmorphic disorder (BDD) have traditionally turned to in order to deal with body-related concerns.

29 Jun 2010

Anxiety News and Research

Latest Anxiety News and Research

Scientist leads global discussion, research on insula

Pelosi urges Democrats to talk up health care; Businesses feel early impact of law

First Edition: July 7, 2010

Therapist competence strongly related to symptom improvement in some patients: Study

Anxiety can cause individuals become more idealistic in religious belief, researchers find

FDA accepts DBV Technologies' IND for clinical study of VIASKIN for desensitization to peanut allergy

Shire receives FDA approval of Daytrana for ADHD in adolescents

Debate over the ill effects of wind turbines on health

Study finds maltreatment during childhood associated with mental health disorders in young adulthood

Anxiety disorders associated with higher risk of cardiovascular events, deaths in heart disease patients

The heart and the psyche – Link between heart disease and anxiety-depressive disorders

Chelsea reports positive outcome from DMC review of droxidopa Phase II trial in fibromyalgia

Does too much texting puts teenagers at risk?

Studies link anti-cholesterol statin drugs to increased risk of anxiety and depression

Calmspace fragrance product to fight claustrophobia

New hope for patients with drug-resistant depression

FDA grants approval for first generic version of Effexor XR antidepressant capsules

Oil spill disaster raises concern in the Gulf region

Combination therapy for severe depression

New therapy for people suffering from body dysmorphic disorder

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Anxiety News and Research

Latest Anxiety News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in